Higher health stocks and falling oil leave S&P 500 flat

Go back to Higher health stocks and falling oil leave S&P 500 flat

Raymond James Cuts Price Target as SolarCity (SCTY) Cuts Installation Guidance

May 10, 2016 9:20 AM EDT

Raymond James maintained a Strong Buy rating on SolarCity (NASDAQ: SCTY), and cut the price target to $50.00 (from $60.00), following the company's 1Q earnings report. Periodic billings revenue of $84.2 million topped estimates of $80.6 million, plus there was upfront system and incentives revenue of $38.4 million. The start to 2016 bookings was slow, largely a function of the regulatory uncertainty in... More

Piper Jaffray Remains Sidelined on Teva Pharma (TEVA) Following 1Q - PT to $58

May 10, 2016 8:04 AM EDT

Piper Jaffray maintained a Neutral rating on Teva Pharma (NYSE: TEVA), and cut the price target to $58.00 (from $59.00), following the company's 1Q earnings report. TEVA reported a non-GAAP EPS of $1.20 on revenues of $4.81B, ahead of the Street's estimates of $1.17 and $4.77B, respectively. Management noted that companies with older, more commodity-focused portfolios should expect... More

Avondale Partners Downgrades SolarCity (SCTY) to Market Perform

May 10, 2016 7:45 AM EDT

Avondale Partners downgraded SolarCity (NASDAQ: SCTY) from Market Outperform to Market Perform.

For an analyst ratings summary and ratings history on SolarCity click here. For more ratings news on SolarCity click here.

Shares of SolarCity closed at $22.51 yesterday.

... More

Baird Remains Sidelined on Wayfair (W) Following 1Q Revenue Beat

May 9, 2016 2:35 PM EDT

Baird maintained a Neutral rating and $50.00 price target on Wayfair (NYSE: W) following the company's 1Q earnings report. Wayfair reported revenues of $747M, ahead of the consensus estimates of $695M and guidance of $600-$700M. The beat was driven by ongoing Direct segment... More